Edit Module

Zoetis to Acquire Nexvet Veterinary Biologic Therapeutics Co.

The acquisition will strengthen Zoetis's portfolio of solutions for chronic pain management in dogs and cats.


Published:

Zoetis Inc. announced it will purchase Nexvet Biopharma veterinary biologic therapeutics company for US $6.72 per share, or a valuation of approximately US $85 million. Pending approval, the purchase is expected to be completed during the second half of 2017. According to Zoetis, headquartered in Parsippany, N.J., the acquisition will strengthen the company’s portfolio of solutions for chronic pain management in dogs and cats.

Nexvet, founded in 2010 and headquartered in Tullamore, Ireland, develops monoclonal antibody (mAb) therapies for companion animals in pain and other therapeutic areas. The company has research and development operations in Melbourne, Australia, a manufacturing facility in Tullamore, and an office in San Francisco.

Nexvet’s pipeline product ranevetmab, an mAb targeting nerve-growth factor for treatment of chronic pain associated with osteoarthritis in dogs, would, upon approval, be the companion animal industry’s first monoclonal antibody therapy administered monthly by injection for chronic pain.

Nexvet is also developing frunevetmab, a monoclonal antibody targeting NGF to treat chronic pain associated with osteoarthritis in cats.

Zoetis’ mAb therapy Cytopoint was licensed in the U.S. in December to control the clinical signs such as itching associated with atopic dermatitis in dogs. The company anticipates its approval in the European Union this year.

Edit Module
Edit ModuleShow Tags

Archive »Read More

Zoetis launches Clavamox Chewable for dogs, cats

Zoetis announced the commercial launch of Clavamox Chewable (amoxicillin and clavulanate potassium tablets), which is effective in treating skin infections in dogs and cats, periodontal infections in dogs, and urinary tract infections in cats, according to the company.

​2017 National Veterinary Scholars Symposium exposes students to biomedical research

Approximately 650 veterinary students and researchers from 38 veterinary schools from the U.S., Canada, the Caribbean, the Netherlands, and France gathered Aug. 3-6 at the National Institutes of Health (NIH) to discuss innovative animal health research and the future of veterinary medicine.

Four reasons veterinary clients avoid regular checkups for their cats—and what you can do about it

A recent survey found 92 percent of cat owners say their cat’s health is important to them, but only half of all American cats taken to the veterinarian by their caretakers on a regular basis; inspire cat owners to participate in Take Your Cat to Vet Day on August 22.
Edit Module
Edit Module
Edit ModuleEdit ModuleShow Tags Edit Module
Edit Module Edit Module
Edit ModuleShow Tags

Events


Show More...
Edit Module
Edit Module